Your browser doesn't support javascript.
loading
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
Filetti, S; Durante, C; Hartl, D M; Leboulleux, S; Locati, L D; Newbold, K; Papotti, M G; Berruti, A.
Affiliation
  • Filetti S; School of Health, Unitelma Sapienza University of Rome, Rome.
  • Durante C; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Hartl DM; Department of Head and Neck Oncology, Gustave Roussy, Villejuif; Université Paris Saclay, Villejuif.
  • Leboulleux S; Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Villejuif, France; Division of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals, Geneva, Switzerland.
  • Locati LD; Translational Oncology, IRCCS ICS Maugeri, Pavia; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
  • Newbold K; Thyroid Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Papotti MG; Department of Pathology, University of Turin, Turin.
  • Berruti A; Department of Medical and Surgical Specialties Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Ann Oncol ; 33(7): 674-684, 2022 07.
Article in En | MEDLINE | ID: mdl-35491008
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular Type of study: Guideline Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular Type of study: Guideline Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article